6640--Automated Antinuclear Antibody (ANA) Analyzer, KC, 36C255-25-AP-1546(VA-26-00000557)

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is soliciting quotes for a Cost-Per-Test (CPT) Blanket Purchase Agreement to procure an Automated Antinuclear Antibody (ANA) analyzer for the Kansas City VA Medical Center. The procurement seeks a single contractor to provide an FDA-approved Indirect Fluorescent Antibody (IFA) slide processing and digital immunofluorescence imaging system, along with associated reagents, supplies, and consumables including comprehensive support services such as 24/7 technical assistance, equipment maintenance, interface capabilities, and validation studies. The contractor must provide the latest model instrumentation, high-quality reagents with at least 12 months of expiration, perform equipment installations, provide training, and ensure continuous inventory of reagents, standards, controls, and supplies. The evaluation criteria include technical capability, past performance, and pricing. The quote submission deadline has been extended to July 17, 2025 at 10:00 AM CDT, with all equipment and peripherals required to be installed and operational by January 2, 2026.

This is an unrestricted solicitation with no set-aside designation, making it open to all qualified contractors. No incumbent or current contractors are identified in the solicitation documents. The BPA has an estimated ceiling limit of $500,000 and will cover five ordering periods spanning from January 2, 2026 to January 1, 2031, consisting of a base year and four option years. The procurement involves leasing instruments with an accompanying reagent purchase agreement, specifically targeting laboratory diagnostic equipment for antinuclear antibody testing. Performance will take place at the Kansas City VA Medical Center, with key points of contact including laboratory management personnel such as the Microbiology Supervisor, Laboratory Manager, and Regional Laboratory Manager.